United Therapeutics (UTHR) Return on Capital Employed Growth (3y) (2013 - 2026)
United Therapeutics (UTHR) Return on Capital Employed Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 1,036.00 |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 175.00 |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 120.00 |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 434.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -295.00 |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 1,076.00 |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 1,898.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.11 Bn | 7.46 Bn | 397.90 Mn | -1,755.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 434.00 |
| Mar 31, 2026 | 480.00 |
| Dec 31, 2025 | 357.00 |
| Sep 30, 2025 | 287.00 |
| Jun 30, 2025 | 249.00 |
| Mar 31, 2025 | 226.00 |
| Dec 31, 2024 | 3,518.00 |
| Sep 30, 2024 | 4,164.00 |
| Jun 30, 2024 | 1,185.00 |
| Mar 31, 2024 | 1,268.00 |
| Dec 31, 2023 | 467.00 |
| Sep 30, 2023 | 343.00 |
| Jun 30, 2023 | 338.00 |
| Mar 31, 2023 | -25.00 |
| Dec 31, 2022 | 2,296.00 |
| Sep 30, 2022 | 2,165.00 |
| Jun 30, 2022 | 2,193.00 |
| Mar 31, 2022 | 2,306.00 |
| Dec 31, 2021 | -1,416.00 |
| Sep 30, 2021 | -1,774.00 |